C127H112N48O8 — CID 159159073
6-[[4-[(5-cyclobutyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one;6-[[4-[(5-cyclopentyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one;6-[[4-[[5-(furan-2-yl)-1H-pyrazol-3-yl]amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one;6-[[4-[[5-(methoxymethyl)-1H-pyrazol-3-yl]amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one;6-[[4-[(5-methyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one;6-[[4-[(5-propan-2-yl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one (PubChem CID 159159073) has the molecular formula C127H112N48O8 and a molecular weight of 2438.62 g/mol. Its IUPAC name is 6-[[4-[(5-cyclobutyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one;6-[[4-[(5-cyclopentyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one;6-[[4-[[5-(furan-2-yl)-1H-pyrazol-3-yl]amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one;6-[[4-[[5-(methoxymethyl)-1H-pyrazol-3-yl]amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one;6-[[4-[(5-methyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one;6-[[4-[(5-propan-2-yl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one.
| Compound Name | 6-[[4-[(5-cyclobutyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one;6-[[4-[(5-cyclopentyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one;6-[[4-[[5-(furan-2-yl)-1H-pyrazol-3-yl]amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one;6-[[4-[[5-(methoxymethyl)-1H-pyrazol-3-yl]amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one;6-[[4-[(5-methyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one;6-[[4-[(5-propan-2-yl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one |
|---|---|
| PubChem CID | 159159073 |
| Molecular Formula | C127H112N48O8 |
| Molecular Weight | 2438.62 g/mol |
| Exact Mass | 2436.98 |
| IUPAC Name | 6-[[4-[(5-cyclobutyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one;6-[[4-[(5-cyclopentyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one;6-[[4-[[5-(furan-2-yl)-1H-pyrazol-3-yl]amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one;6-[[4-[[5-(methoxymethyl)-1H-pyrazol-3-yl]amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one;6-[[4-[(5-methyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one;6-[[4-[(5-propan-2-yl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]-1,2-dihydroindazol-3-one |
| SMILES | CC(C)c1cc(Nc2nc(Nc3ccc4c(=O)[nH][nH]c4c3)nc3ccccc23)n[nH]1.COCc1cc(Nc2nc(Nc3ccc4c(=O)[nH][nH]c4c3)nc3ccccc23)n[nH]1.Cc1cc(Nc2nc(Nc3ccc4c(=O)[nH][nH]c4c3)nc3ccccc23)n[nH]1.O=c1[nH][nH]c2cc(Nc3nc(Nc4cc(-c5ccco5)[nH]n4)c4ccccc4n3)ccc12.O=c1[nH][nH]c2cc(Nc3nc(Nc4cc(C5CCC5)[nH]n4)c4ccccc4n3)ccc12.O=c1[nH][nH]c2cc(Nc3nc(Nc4cc(C5CCCC5)[nH]n4)c4ccccc4n3)ccc12 |
| InChI | InChI=1S/C23H22N8O.C22H16N8O2.C22H20N8O.C21H20N8O.C20H18N8O2.C19H16N8O/c32-22-16-10-9-14(11-19(16)29-31-22)24-23-25-17-8-4-3-7-15(17)21(27-23)26-20-12-18(28-30-20)13-5-1-2-6-13;31-21-14-8-7-12(10-16(14)27-30-21)23-22-24-15-5-2-1-4-13(15)20(26-22)25-19-11-17(28-29-19)18-6-3-9-32-18;31-21-15-9-8-13(10-18(15)28-30-21)23-22-24-16-7-2-1-6-14(16)20(26-22)25-19-11-17(27-29-19)12-4-3-5-12;1-11(2)16-10-18(28-26-16)24-19-13-5-3-4-6-15(13)23-21(25-19)22-12-7-8-14-17(9-12)27-29-20(14)30;1-30-10-12-9-17(27-25-12)23-18-13-4-2-3-5-15(13)22-20(24-18)21-11-6-7-14-16(8-11)26-28-19(14)29;1-10-8-16(26-24-10)22-17-12-4-2-3-5-14(12)21-19(23-17)20-11-6-7-13-15(9-11)25-27-18(13)28/h3-4,7-13H,1-2,5-6H2,(H2,29,31,32)(H3,24,25,26,27,28,30);1-11H,(H2,27,30,31)(H3,23,24,25,26,28,29);1-2,6-12H,3-5H2,(H2,28,30,31)(H3,23,24,25,26,27,29);3-11H,1-2H3,(H2,27,29,30)(H3,22,23,24,25,26,28);2-9H,10H2,1H3,(H2,26,28,29)(H3,21,22,23,24,25,27);2-9H,1H3,(H2,25,27,28)(H3,20,21,22,23,24,26) |
| InChIKey | KKGOTJZLMJZODQ-UHFFFAOYSA-N |
| XLogP | 23.82 |
| TPSA | 785.39 Ų |
| H-Bond Donors | 30 |
| H-Bond Acceptors | 38 |
| Rotatable Bonds | 30 |
| Heavy Atoms | 183 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2438.62 |
| LogP ≤ 5 | 23.82 |
| H-Bond Donors ≤ 5 | 30 |
| H-Bond Acceptors ≤ 10 | 38 |